Ormeloxifene treatment inhibits growth of cisplatin-resistant ovarian cancer cells

被引：0
|
作者：
Nordquist, Jordan [1 ,2 ]
Maher, Diane M. [1 ]
Ebeling, Mara [1 ]
Jaggi, Meena [1 ,3 ,4 ]
Chauhan, Subhash C. [1 ,3 ,4 ]
机构：
[1] Sanford Res USD, Canc Biol Res Ctr, Sioux Falls, SD USA
[2] Univ S Dakota, Sanford Sch Med, Sioux Falls, SD USA
[3] Univ S Dakota, Sanford Sch Med, Dept OB GYN, Sioux Falls, SD USA
[4] Univ S Dakota, Sanford Sch Med, Basic Biomed Sci Div, Sioux Falls, SD USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-4521
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4521
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Vandetanib inhibits cisplatin-resistant neuroblastoma tumor growth and invasion
    Li, Changchun
    Yang, Chao
    Wei, Guanghui
    ONCOLOGY REPORTS, 2018, 39 (04) : 1757 - 1764
  • [22] Isoalantolactone Suppresses Glycolysis and Resensitizes Cisplatin-Based Chemotherapy in Cisplatin-Resistant Ovarian Cancer Cells
    Chun, Jaemoo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [23] Anlotinib suppresses growth and metastasis through MAPK signaling pathway in cisplatin-resistant ovarian cancer cells.
    Ji, Yurou
    Qu, Pengpeng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17542 - E17542
  • [24] Redox resetting of cisplatin-resistant ovarian cancer cells by cisplatin-encapsulated nanostructured lipid carriers
    Mittal, Disha
    Biswas, Largee
    Verma, Anita Kamra
    NANOMEDICINE, 2021, 16 (12) : 979 - 995
  • [25] Poly(amido)amine (PAMAM) dendrimer–cisplatin complexes for chemotherapy of cisplatin-resistant ovarian cancer cells
    Venkata Kashyap Yellepeddi
    Kiran Kumar Vangara
    Srinath Palakurthi
    Journal of Nanoparticle Research, 2013, 15
  • [26] Anti-cancer effects of Pt(IV) complex in cisplatin-resistant ovarian cancer cells
    Tobe, Takao
    Shimizu, Karin
    Motoyama, Miki
    Ueda, Koji
    Okamoto, Yoshinori
    Kojima, Nakao
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2014, 19 : S831 - S831
  • [27] GALLIC ACID EXHIBITS LOWER CYTOTOXICITY ON NORMAL OVARIAN CELLS THAN CISPLATIN-SENSITIVE AND CISPLATIN-RESISTANT OVARIAN CANCER CELLS
    Al Balushi, N.
    Abdulla, N.
    Al Dhahli, B.
    Hasan, I.
    Dobretsov, S.
    Al Bahlani, S.
    Tsang, B.
    Tamimi, Y.
    Burney, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A430 - A430
  • [28] Characterization of mitochondria in cisplatin-resistant human ovarian carcinoma cells
    Hirama, Masanori
    Isonishi, Seiji
    Yasuda, Makoto
    Ishikawa, Hiroshi
    ONCOLOGY REPORTS, 2006, 16 (05) : 997 - 1002
  • [29] CHEMOSENSITIZING EFFECTS OF LOW MOLECULAR WEIGHT HEPARIN ON CISPLATIN-RESISTANT OVARIAN CANCER CELLS
    Pfankuchen, Daniel
    Stoeking, Daniel P.
    Bendas, Gerd
    ANTICANCER RESEARCH, 2014, 34 (10) : 6112 - 6112
  • [30] Targeting c-MYC in cisplatin-resistant ovarian cancer
    Reyes, Jeyshka
    Ivan, Cristina
    Sood, Anil K.
    Vivas-Mejia, Pablo E.
    CLINICAL CANCER RESEARCH, 2013, 19
12345